Mr. Herzich is the Chief Technology Officer and leads technology and manufacturing activities across all Solid programs.
Mr. Herzich has served as the Chief Technology Officer of Solid Biosciences, a gene therapy company, since December 2022. Mr. Herzich served as the Chief Technology Officer for AavantiBio from April 2021 to December 2022.
Prior to joining AavantiBio, Mr. Herzich previously served as Vice President, CMC at BridgeBio Pharma, Inc., a biopharmaceutical company, from August 2020 to April 2021. Previously, Mr. Herzich served as Head of Manufacturing Operations at BridgeBio from July 2019 to July 2020. Prior to joining BridgeBio, Mr. Herzich served as Senior Director of Manufacturing at LogicBio Therapeutics, Inc., a genetic medicine company, from January 2018 to July 2019. Mr. Herzich served as Senior Manager and Director of cGMP Gene Therapy Manufacturing at Bamboo Therapeutics (acquired by Pfizer) from August 2016 to January 2018. From July 2015 to August 2016, Mr. Herzich served as the head of TD manufacturing from CSL Seqirus, a pharmaceutical company, and from December 2007 to July 2015, Mr. Herzich served in various roles at CSL Seqirus (acquired by Novartis Vaccines and Diagnostics, Inc.), a pharmaceutical manufacturing company. Mr. Herzich holds a Master of Business Administration from North Carolina State University Poole College of Management and a Bachelor of Science in Biology from Rutgers University.
What is Paul Herzich's net worth?
The estimated net worth of Paul Herzich is at least $157.60 thousand as of December 3rd, 2025. Mr. Herzich owns 26,622 shares of Solid Biosciences stock worth more than $157,602 as of December 4th. This net worth approximation does not reflect any other assets that Mr. Herzich may own. Learn More about Paul Herzich's net worth.
How old is Paul Herzich?
Mr. Herzich is currently 46 years old. There are 6 older executives and no younger executives at Solid Biosciences. The oldest executive at Solid Biosciences is Mr. Ian F. Smith A.C.A., C.P.A., Executive Chair, who is 58 years old. Learn More on Paul Herzich's age.
How do I contact Paul Herzich?
Has Paul Herzich been buying or selling shares of Solid Biosciences?
Within the last three months, Paul Herzich has sold $13,802.11 of Solid Biosciences stock. Most recently, Paul Herzich sold 2,701 shares of the business's stock in a transaction on Wednesday, December 3rd. The shares were sold at an average price of $5.11, for a transaction totalling $13,802.11. Following the completion of the sale, the chief technology officer now directly owns 26,622 shares of the company's stock, valued at $136,038.42. Learn More on Paul Herzich's trading history.
Who are Solid Biosciences' active insiders?
Are insiders buying or selling shares of Solid Biosciences?
During the last twelve months, Solid Biosciences insiders bought shares 1 times. They purchased a total of 1,860 shares worth more than $9,932.40. During the last twelve months, insiders at the sold shares 8 times. They sold a total of 31,092 shares worth more than $155,239.01. The most recent insider tranaction occured on December, 3rd when COO David T Howton sold 4,932 shares worth more than $25,202.52. Insiders at Solid Biosciences own 1.9% of the company.
Learn More about insider trades at Solid Biosciences. Information on this page was last updated on 12/3/2025.
